The Quantellect read.As of Nov 19, 2026, 20 active firms cover Humana Inc: 11 rate it Buy or better, 8 sit at Neutral, and 1 rate it Sell or worse, a neutral consensus. The target range is very wide, $158.00 to $596.00 (about 3.8x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $430.85 sits 12% above the current $386.35. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 7 to 11 over recent months. On the fundamentals, the Street sees consensus EPS building from about $13.20 next quarter toward $18.16 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS20 active firms
Neutral
Strong Buy00%
Buy1155%
Neutral840%
Sell15%
Strong Sell00%
Based on 20 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$430.85
+11.5% upside
Average target across 20 active firms as of Nov 19, 2026 vs $386.35 current
Highest Target$596.00
Average Target$430.85
Lowest Target$158.00
Detailed analyst forecasts for HUM
Showing 1–20 of 20 named analysts shown · 20 active firms in the rating projection
As of Nov 19, 2026, 11 of 20 active firms rate HUM a Buy (8 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
HUM EPS & revenue forecast
EPS · NEXT QUARTER
$13.20
Range $11.21 – $15.60 · 16 analysts · +28% YoY
Next period, 16 analysts expect Humana Inc to earn $13.20 a share (range $11.21 – $15.60), versus $10.31 a year earlier. Full-year consensus is $9.52, growing to $18.16 the year after.
REVENUE · NEXT QUARTER
$43.0B
Range $41.1B – $44.9B · 16 analysts · +8% YoY
Revenue is expected to reach $43.0B (range $41.1B – $44.9B), +8.4% year-over-year. Full-year consensus is $162.9B, rising to $173.6B next year.
Top analysts covering Humana Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on HUM.
#1
Stephen Baxter
Wells Fargo · Rank #63
Buy
$502.00+29.9% to target
Overall win rate
47%
+ Follow
#2
Erin Wright
Morgan Stanley · Rank #81
Neutral
$370.00-4.2% to target
Overall win rate
55%
+ Follow
#3
DM
David Macdonald
Truist Securities · Rank #111
Neutral
$475.00+22.9% to target
Overall win rate
50%
+ Follow
#4
Ben Hendrix
RBC Capital · Rank #150
Neutral
$415.00+7.4% to target
Overall win rate
44%
+ Follow
#5
Sarah James
Cantor Fitzgerald · Rank #159
Buy
$495.00+28.1% to target
Overall win rate
37%
+ Follow
HUM stock forecast FAQ
What is HUM's average 12-month price target?+
The 20 active firms with a live target average $430.85 for Humana Inc over the next 12 months, ranging from a $596.00 high to a $158.00 low, as of Nov 19, 2026.
Is HUM stock a Buy, Sell or Neutral right now?+
The current consensus is Neutral. Of the 20 active firms as of Nov 19, 2026, 11 rate it Buy or Strong Buy, 8 rate it Neutral, and 1 rate it Sell or Strong Sell.
What are the highest and lowest price targets for HUM?+
The Street-high target is $596.00 (Baird), and the Street-low is $158.00 (Goldman Sachs). The average of all 20 active-firm targets is $430.85.
How many active Wall Street firms cover HUM?+
20 active firms have a recognized rating on Humana Inc as of Nov 19, 2026, and 20 active firms carry a live 12-month price target.
Who is the most accurate analyst covering HUM?+
Among analysts who currently cover HUM, Stephen Baxter of Wells Fargo has the strongest overall Quantellect track record (Rank #63). Their current call is Buy with a $502.00 target.
What is Humana Inc's projected EPS for next quarter?+
The consensus estimate is $13.20 per share (range $11.21 – $15.60) across 16 analysts. Full-year EPS is projected at $9.52, rising to $18.16 the following year.
How much revenue is Humana Inc expected to report next quarter?+
Consensus revenue is $43.0B (range $41.1B – $44.9B). Full-year revenue is projected at $162.9B, growing to $173.6B next year.
Have analysts been upgrading or downgrading HUM lately?+
As of Nov 19, 2026, 11 of 20 active firms rate HUM a Buy (8 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their HUM calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.